Vancomycin-sensitive and vancomycin-resistant enterococcal infections in the ICU: Attributable costs and outcomes

Intensive Care Medicine

Volumn 28, Issue 6, 2002, Pages 692-697

  Pelz, Robert K ^a   Lipsett, Pamela A ^a   Swoboda, Sandra M ^a   Diener West, Marie ^b   Powe, Neil R ^b,c   Brower, Roy G ^a   Perl, Trish M ^a   Hammond, Janet M ^d   Hendrix, Craig W ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c JOHNS HOPKINS HOSPITAL   (United States)

^d GLAXOSMITHKLINE   (United States)

Author keywords

Cost; Enterococcus species; Epidemiology; Outcome; Vancomycin; Vancomycin resistance

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMPICILLIN; CHLORAMPHENICOL; RIFAMPICIN; TETRACYCLINE; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL INFECTION; BACTERIAL STRAIN; COHORT ANALYSIS; CONTROLLED STUDY; CRITICAL ILLNESS; DEMOGRAPHY; ECONOMIC ASPECT; ENTEROCOCCUS; FEMALE; GASTROINTESTINAL INFECTION; HIGH RISK POPULATION; HOSPITAL COST; HOSPITALIZATION; HUMAN; INTENSIVE CARE; INTENSIVE CARE UNIT; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MULTIPLE REGRESSION; PROSPECTIVE STUDY;

ANTI-BACTERIAL AGENTS; APACHE; BACTERIAL INFECTIONS; ENDPOINT DETERMINATION; ENTEROCOCCUS; FEMALE; HOSPITAL MORTALITY; HUMANS; INTENSIVE CARE UNITS; LENGTH OF STAY; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; TREATMENT OUTCOME; VANCOMYCIN; VANCOMYCIN RESISTANCE;

EID: 0036278148     PISSN: 03424642     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00134-002-1276-8     Document Type: Article

References (19)

1. Plasmid-mediated resistance to vancomycin and teicoplanin in Enterococcus faecium
2. Nosocomial enterococci resistant to vancomycin - United States, 1989-1993
3. Data summary from October 1986-April 1997
4. Vancomycin-resistant enterococci
5. Epidemiology and mortality risk of vancomycin-resistant enterococcal bloodstream infections
6. Differences in outcomes for patients with bacteremia due to vancomycin-resistant Enterococcus faecium or vancomycin-susceptible E. faecium
7. Enterococcus faecium bacteremia. Does vancomycin resistance make a difference?
8. Enterococcal bacteremia in the surgical intensive care unit. Does vancomycin resistance affect mortality?
9. Vancomycin-resistant and vancomycin-susceptible enterococcal bacteremia: Comparison of clinical features and outcomes
10. Nosocomial bloodstream infection in critically ill patient. Excess length of stay, extra costs, and attributable mortality
11. Recommendations for preventing the spread of vancomycin resistance
12. A semiquantitative method for identifying intravenous-catheter-related infection
13. Draft guidelines for the prevention of surgical site infection
14. Least absolute deviations curve-fitting
15. Enterococcal bacteremia: Risk factors for vancomycin resistance and predictors of mortality
16. Determinants of vancomycin resistance and mortality rates in enterococcal bacteremia. A prospective multicenter study
17. Association between resistance to vancomycin and death in cases of Enterococcus faecium bacteremia
18. Cost of hospitalization for and risk factors associated with vancomycin resistant Enterococcus faecium. Infection and colonization